Skip to main content

1 Result(s)

within Takaaki Furukawa Remove this filter Biomedicine, general Remove this filter

and

  1. Article

    Open Access

    Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer

    There is no established second-line treatment after failure of gemcitabine plus nab-paclitaxel (GnP) therapy for metastatic pancreatic cancer (MPC). The purpose of this study was to evaluate the efficacy and t...

    Masashi Sawada, Akiyoshi Kasuga, Takafumi Mie, Takaaki Furukawa… in BMC Cancer (2020)

    Download PDF (773 KB) View Article